Igor Barjaktarević

Professional activities:

Pulmonary Grand Rounds, “The role of Interleukin IL23 in development of emphysema in HIV+ smokers”, David Geffen School of Medicine, UCLA, April 2012

Lecturer David Geffen School of Medicine Faculty – Block 1: Anatomy Curriculum: cadaver course, UCLA medical students: airway and thoracic procedures, 2012-2015

Lecturer David Geffen School of Medicine Faculty – Block 8: Physiology Curriculum MS1,

David Geffen School of Medicine: “Cardiovascular, Renal & Respiratory Medicine I” 2016-2019

Committee service:

·       Critical care committee of UCLA

·       Medical ICU subcommittee

·       Quality assurance committee

·       Liver transplant selection committee, 2012-present.

·       UCLA Department of Medicine Quality Council, 2015

·       UCLA Pulmonary Embolism Response Team, 2016

·       Pulmonary Division Fellowship selection committee

Lead physician: Lung Nodule clinic, UCLA Westwood campus, Ronald Reagan Medical Center; 2013

Faculty, Instructor: 3rd Goal-Directed Therapy Symposium, Newport Beach, CA, November 2013

Faculty, Lecturer: 19^th and 20^th Annual UCLA Symposium: Pulmonary Function and Exercise Testing, 2013, 2014

Ultrasound Instructor: The Implementation of a Formal Curriculum for Bedside Ultrasound at UCLA, 2014-present

American Thoracic Society: Lead Discussion Facilitator, Thematic Poster Session, ATS 2014; Facilitator, Thematic Poster Session, ATS 2015; Lead Discussion Facilitator, Thematic Poster Session, ATS 2016

American Thoracic Society: Thoracic Oncology Assembly Programming Committee, 2014-2017 Department of Medicine Grand Rounds, David Geffen School of Medicine at UCLA, September

2015: “Emerging role of Ultrasound in bedside diagnostics”

Pulmonary Grand Rounds, Harbor UCLA Medical Center, Oct 2015: “Endobronchial ultrasound: transient trend or step forward?”

Director, First, Second and Fifth Regional South California Critical Care Ultrasound Training, USC and UCLA, 2015, 2016, 2019

Pulmonary  Grand  Rounds,  David  Geffen  School  of  Medicine  at  UCLA,  Dec  2015:

“Endobronchial ultrasound: transient trend or step forward?”

American Thoracic Society: Proficiency Standards for Pulmonary Function Laboratories Committee (2016 – 2023)

Faculty member, Ultrasonography: Essential in Critical Care, CHEST 2016, Los Angeles Pulmonary lecture series, guest faculty - Asahi General Hospital, Japan, May 2016

Clinical Resource Center for Alpha-1 Foundation; Alpha-1 Antitrypsin Deficiency Syndrome clinic lead, 200 Medical Plaza

Pulmonary Grand Rounds, David Geffen School of Medicine at UCLA, January 2018: “Carotid Flow Time Study: The Role of Ultrasound in Fluid Resuscitation in Shock”

Department of Medicine Grand Rounds, David Geffen School of Medicine at UCLA, November

2018: “Positioning new pharmacotherapies in COPD”

American Medical Foundation, Los Angeles 2018: “Positioning new pharmacotherapies in COPD” and “Alpha-1 Antitrypsin Deficiency – a Rare Disease?”

European Respiratory Society, 2018: “Reduced FEV3/FVC identifies smokers at risk of

developing COPD in the SPIROMICS cohort”

ATS 2018, “Clinical Implications of Bronchodilator Responsiveness in SPIROMICS”

Medical School Faculty – Block 2: Physiology Curriculum MS1, David Geffen School of

Medicine: “Cardiovascular, Renal & Respiratory Medicine I” 2016-2019

American Thoracic Society: Proficiency Standards for Pulmonary Function Laboratories Committee (2016-2022), member of the ATS/ERS Spirometry Technical Standards Committee

Physician Advisor, International Services, David Geffen School of Medicine, UCLA, 2018

Guest lecturer: University of Belgrade, Serbia. “New approached in management of emphysema”, September 2018, “End-stage respiratory failure in interstitial lung diseases, an intensivist’s perspective”, April 2019, “Alpha-1 Antitrypsin Deficiency”, July 2018

Training Program in Translational Science, Clinical & Translational Science Institute, David Geffen School of Medicine, UCLA, 2018-2020

Grand Round in Allergy, David Geffen School of Medicine at UCLA, “Alpha-1 antitrypsin: a

rare disease?”, January 2020

Critical Care Grand Rounds, David Geffen School of Medicine at UCLA, “Fluid management in

shock – beyond the written rules”, February 2020

Alpha-1 Foundation: Medical and Scientific Advisory Committee Member, 2021-Present Center for Rare Diseases (CCRD), collaborator - David Geffen School of Medicine, UCLA Visiting Faculty lecturer – PhD studies in pulmonary medicine – University of Belgrade, 2022-

Visiting Faculty lecturer - Critical Care Medicine Fellowship lecturer - University of Belgrade, 2021-present

Alpha-1 Foundation MASAC - Medical and Scientific Advisory Committee member for Alpha- 1 Antitrypsin Deficiency, Board member 2021 - current

COPD Foundation's Nebulizer Consortium (CNC) - Lead clinician scientist for the Research Pillar of the Consortium

University of Miami, Inaugural Function Lung Imaging conference, invited speaker, :Ventilaton

Heterogeneity”, January 2023

Congress of Respiratory Society of Serbia, April 2023, Vrnjacka Banja, Session chair and invited

speaker: “Alpha-1 Antitrypsin Deficiency, a rare disease?”

ATS 2023: Mini Symposium: Emerging COPD Diagnosis and Treatments: “Ensifentrine, a novel dual PDE3 and PDE4 inhibitor, improves lung function and reduces exacerbation rate and risk:

ATS 2023: Mini Symposium: Novel Imaging and Physiologic Measures in COPD: Ventilation Heterogeneity in COPD

Alpha-1 Foundation: Grant Advisory Committee member, 2023

25th Gordon L. Snider Critical Issues Workshop, Oct 2, 2023, Washington D.C.: “Longitudinal analysis of clinical outcomes in Pi*MZ alpha-1 antitrypsin deficiency smokers from the SPIROMICS cohort

GOLD 2023: “Inflammation heterogeneity in COPD”

ATS 2024: “Epithelial Cytokines: connecting the dots in severe asthma, nasal polyposis and

COPD”, May 2024

UCLA Advanced Lung Disease and Lung Transplant Symposium - Updates in the management of COPD, Apr 2024